BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $3 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | 193.8% | 131.5% | -143.5% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 100% | 352.4% | 100% | 10.7% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 97.6% | 244.4% | 101.9% | 99.1% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 97.4% | 244.3% | 101.9% | 99.1% |
| EPS Diluted | 1.77 | 1.44 | -2.1 | -2.55 |
| % Growth | 22.9% | 168.6% | 17.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |